Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Tech, non-tech sectors mixed on recommended carbon fees
10/07/2024 11:10 PM - Business
Taiwan's recommended carbon fee too low: Environmental groups
10/07/2024 11:02 PM - Science & Tech
New study finds 'adequate' fruit, vegetable diet can boost life expectancy
10/07/2024 10:30 PM - Politics
Tai Tzu-ying becomes Taiwan's youngest ambassador-at-large
10/07/2024 10:15 PM - Society
No major losses for Taiwanese companies from recent cyberattacks: MODA
10/07/2024 09:31 PM